Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix
Clinical trial NCT00693706 · COMPLETED
Trial details
- NCT number
- NCT00693706
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-02
- Primary completion
- 2009-03-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.